NCT02161432View on ClinicalTrials.gov

Relative Bioavailability of a BI 187004 Tablet Formulation in Comparison With an Oral Solution and the Influence of Food on the Tablet Formulation in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Healthy
Interventions
DRUG

BI 187004

single dose BI 187004 given as tablet in fed state

DRUG

BI 187004

single dose BI 187004 given as tablet in fasted state

DRUG

BI 187004

single dose BI 187004 given as oral solution

Trial Locations (1)

Unknown

1307.3.1 Boehringer Ingelheim Investigational Site, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY